MacroGenics to Participate in Two Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
MacroGenics (MGNX) PT Lowered to $42 at Stifel; Reiterates Buy
March 1, 2017 9:03 AM ESTStifel lowered its price target on MacroGenics (NASDAQ: MGNX) to $42.00 (from $51.00) while maintaining a Buy rating.
Analyst Stephen Willey commented, "Managements relatively quiet 4Q16 earnings announcement/call was expected following the comprehensive pipeline update provided at the December 2016 R&D Day. The... More



